Lung Cancer Clinical Trial
An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions
Summary
This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.
Eligibility Criteria
Inclusion Criteria:
Patient seen within the St. Elizabeth system
>=18 years of age
New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later
Exclusion Criteria:
Patients with metastatic lung disease of other primary
Other malignancies at investigator's discretion
Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC
Patient currently undergoing treatment for new diagnosis of lung cancer
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Edgewood Kentucky, 41017, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.